Overview

Neuropeptides in Human Reproduction

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators are seeking healthy volunteers and volunteers with reproductive disorders for the study of the role of dynorphin in the reproductive system. Dynorphin is a naturally occurring opioid hormone that is blocked by naloxone. We hypothesize that naloxone, by blocking dynorphin, will stimulate production of GnRH and kisspeptin, 2 other naturally occurring reproductive hormones.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Hormones
Naloxone
Criteria
Inclusion Criteria:

- Ages 21-40 (healthy men and regularly cycling women) OR ages 18-75 (men and women with
hypogonadotropic hypogonadism (HH))

- Normal blood pressure (systolic BP <140 mm Hg, diastolic BP <90 mm Hg)

- White blood cell, platelets, prolactin, and thyroid stimulating hormone (TSH)within
90%-110% of laboratory reference range

- Negative urine drug screen panel

- Hemoglobin:

1. For healthy men and healthy regularly cycling women: normal

2. For men and women with HH: No less than 0.5 gm/dL below the lower limit of the
reference range for normal women

- Blood urea nitrogen (BUN), creatinine, liver function tests not elevated

- For healthy subjects: Normal reproductive function and history

- For healthy subjects: Body Mass Index (BMI) 18.5-30kg/m2

- For subjects with HH: All medical conditions stable and well controlled

Exclusion Criteria:

- History of medication reaction requiring emergency medical attention

- Illicit drug use

- Consumption of more than 10 alcoholic drinks per week

- Difficulty with blood draws

- Currently seeking fertility, breastfeeding, or pregnant

- For healthy subjects: history of chronic disease and prescription medication use (with
the exception of seasonal allergy medication)

- For subjects with HH: prescription medications known to affect reproductive endocrine
function except for those used to treat the subject's reproductive condition